Prestige Consumer Healthcare
318 hedge funds and large institutions have $2.54B invested in Prestige Consumer Healthcare in 2026 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 111 increasing their positions, 123 reducing their positions, and 73 closing their positions.
3.52% more ownership
Funds ownership: 109.85% → 113.37% (+3.5%)
10% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 123
10% less funds holding
Funds holding: 355 → 318 (-37)
17% less capital invested
Capital invested by funds: $3.08B → $2.54B (-$535M)
41% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 73
82% less call options, than puts
Call options by funds: $5K | Put options by funds: $28K
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$120M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$61.5M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
+$30.5M |
| 4 |
BlackRock
New York
|
+$22.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$19.6M |
Top Sellers
PBH Hedge Fund Activity: Q2 2026 in Review
318 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q2 2026, worth a combined $2.54B — down 17% from $3.08B a quarter earlier.
Sellers outnumbered buyers: 73 funds closed out of PBH and 43 opened new positions — a net loss of 30 holders — while 123 trimmed existing stakes and 111 added.
The largest buyer was Fuller & Thaler Asset Management, opening a new position worth an estimated $120M. The largest seller was Nomura Asset Management International, exiting entirely with an estimated $63.4M sold.
- 318 institutional investors held Prestige Consumer Healthcare (PBH) as of Q2 2026, down from 355 in Q1 2026.
- Funds reported $2.54B of Prestige Consumer Healthcare stock for Q2 2026, down 17% quarter-over-quarter.
- 43 funds opened new Prestige Consumer Healthcare positions in Q2 2026 and 73 closed out, a net change of -30 holders.
- The largest Prestige Consumer Healthcare buyer in Q2 2026 was Fuller & Thaler Asset Management, an estimated $120M added.
- The largest Prestige Consumer Healthcare seller in Q2 2026 was Nomura Asset Management International, an estimated $63.4M sold.
Based on aggregated 13F filings for Q2 2026.